Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd

SZSE:000766.SZ

13.05 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994
Revenue 1,462.6721,470.7491,515.4821,111.8021,977.2062,094.5491,521.41850.083197.559208.415147.782127.648181.471169.587168.164159.856151.589141.337141.15399.872136.897160.995100.435504.187284.91270.987241.071163.868132.48999.435
Cost of Revenue 410.35353.209352.84224.302339.902341.363324.066265.73196.44879.37672.23457.30276.35165.84865.56164.3467.12866.02758.77649.750.14139.43430.47470.477103.892114.27775.38947.6850.47349.94
Gross Profit 1,052.3221,117.541,162.642887.5011,637.3051,753.1871,197.344584.353101.111129.03975.54870.346105.12103.739102.60395.51684.4675.31182.37650.17286.756121.56269.961433.711181.017156.71165.682116.18882.01649.495
Gross Profit Ratio 0.7190.760.7670.7980.8280.8370.7870.6870.5120.6190.5110.5510.5790.6120.610.5980.5570.5330.5840.5020.6340.7550.6970.860.6350.5780.6870.7090.6190.498
Reseach & Development Expenses 44.93164.90963.51550.3366.91267.30351.5528.5820.2631.6680.710000000000000000000
General & Administrative Expenses 29.36625.51330.099105.38873.39954.52239.7144.12814.85318.23913.79211.81641.7733.77733.80730.62130.88935.18235.46182.599148.29647.87154.762.41135.71821.75415.649.1816.3953.242
Selling & Marketing Expenses 792.067815.145878.708856.7581,290.461,244.005702.623215.8563.73769.76648.57234.10257.16653.92853.21942.13336.09635.06634.75792.25371.96662.014213.00560.28238.70225.47534.20525.70622.93618.401
SG&A 881.734840.658908.807962.1461,363.8591,298.527742.333259.97878.59188.00562.36445.91898.93687.70487.02672.75466.98570.24870.217274.852220.262109.883367.705122.69274.4247.22949.84434.88729.33221.643
Other Expenses -2.02882.94667.34449.42378.7571.4550.2315.1551.197-7.2921.953-1.7814.9224.2378.4761.8217.0882.813-0.198-9.687-17.07837.149-209.58552.29622.65818.8968.9572.077-0.382-0.003
Operating Expenses 928.693988.5121,039.6671,061.8991,509.5281,442.805893.282363.785116.03123.64991.73375.391101.26889.88788.99374.74468.84271.89671.592275.338221.04112.346369.734130.77877.39149.47952.7436.29330.48121.936
Operating Income 123.629139.167146.089-174.398158.678407.791299.691233.7594.80816.0193.2486.85811.4867.10620.57814.77612.3775.7118.789-275.025-178.484-20.621-366.587265.80193.917102.892103.92775.39152.42724.8
Operating Income Ratio 0.0850.0950.096-0.1570.080.1950.1970.2750.0240.0770.0220.0540.0630.0420.1220.0920.0820.040.062-2.754-1.304-0.128-3.650.5270.330.380.4310.460.3960.249
Total Other Income Expenses Net -65.033-88.993-86.466-181.434-2,171.42398.864-4.14127.21320.6513.33521.38710.12312.555-2.79415.444-4.1763.9144.991-2.129-59.673-59.6047.584-275.91114.46410.6929.395-0.258-2.0880.522-2.853
Income Before Tax 58.59750.17459.624-355.832-2,012.745409.246299.921247.7815.7338.7255.2015.07716.40811.05829.05416.59719.5328.4658.623-284.775-194.72516.664-575.928317.747115.447119.207112.78477.63852.05124.751
Income Before Tax Ratio 0.040.0340.039-0.32-1.0180.1950.1970.2910.0290.0420.0350.040.090.0650.1730.1040.1290.060.061-2.851-1.4220.104-5.7340.630.4050.440.4680.4740.3930.249
Income Tax Expense 11.62920.98525.6354.82830.19180.02642.83235.86-1.1313.5591.1091.2215.166-0.961-0.737-0.5830.70317.0310-50.566-15.15667.8457.01670.37833.65932.57317.1811.6425.1881.9
Net Income 43.93430.15135.273-360.66-2,042.936330.858257.879213.4616.8635.1664.0923.85711.24112.01929.79117.1818.82916.518.476-245.679-194.2716.417-584.125241.91581.34683.3195.48465.99646.86322.851
Net Income Ratio 0.030.0210.023-0.324-1.0330.1580.170.2510.0350.0250.0280.030.0620.0710.1770.1070.1240.1170.06-2.46-1.4190.102-5.8160.480.2860.3070.3960.4030.3540.23
EPS 0.0460.0310.037-0.37-2.110.340.270.230.010.010.010.010.030.030.070.040.04-0.020.019-0.57-0.450.037-1.360.540.180.170.250.150.110.053
EPS Diluted 0.0460.0310.037-0.37-2.110.340.270.230.010.010.010.010.030.030.070.040.04-0.020.019-0.57-0.450.037-1.360.540.180.170.250.150.110.053
EBITDA 198.659210.785215.477-80.518226.517414.548400.095324.9329.27436.02430.22619.28926.41242.21724.08745.05438.77523.75328.702-221.713-132.44391.469-475.945386.582116.892127.589112.94279.89551.53627.559
EBITDA Ratio 0.1360.1430.142-0.0720.1150.1980.2630.3820.1480.1730.2050.1510.1460.2490.1430.2820.2560.1680.203-2.22-0.9670.568-4.7390.7670.410.4710.4690.4880.3890.277